Published in Transl Psychiatry on October 18, 2011
Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry (2013) 1.46
Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron (2012) 1.29
Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol (2012) 1.21
Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci (2015) 1.13
Maternal autoantibodies in autism. Arch Neurol (2012) 1.08
Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology (2014) 1.02
Maternal and fetal antibrain antibodies in development and disease. Dev Neurobiol (2012) 0.86
Prenatal Exposure to Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells, Enlarges Brain, and Increases Neuronal Size in Adult Animals. Cereb Cortex (2014) 0.86
The Impact of Neuroimmune Alterations in Autism Spectrum Disorder. Front Psychiatry (2015) 0.86
Transcriptional regulation of the MET receptor tyrosine kinase gene by MeCP2 and sex-specific expression in autism and Rett syndrome. Transl Psychiatry (2013) 0.85
Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors. Brain Behav Immun (2012) 0.85
Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatry (2016) 0.82
The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology (2016) 0.82
MET and AKT genetic influence on facial emotion perception. PLoS One (2012) 0.79
The Pleiotropic MET Receptor Network: Circuit Development and the Neural-Medical Interface of Autism. Biol Psychiatry (2016) 0.78
Autoimmunity, Autoantibodies, and Autism Spectrum Disorder. Biol Psychiatry (2016) 0.78
Complete or partial reduction of the Met receptor tyrosine kinase in distinct circuits differentially impacts mouse behavior. J Neurodev Disord (2015) 0.78
Neuroinflammation - using big data to inform clinical practice. Nat Rev Neurol (2016) 0.75
Autism-specific maternal anti-fetal brain autoantibodies are associated with metabolic conditions. Autism Res (2016) 0.75
Is 'bench-to-bedside' realistic for autism? An integrative neuroscience approach. Neuropsychiatry (London) (2013) 0.75
Mechanisms regulating dendritic arbor patterning. Cell Mol Life Sci (2017) 0.75
Met, metastasis, motility and more. Nat Rev Mol Cell Biol (2003) 14.30
Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry (2011) 6.98
Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96
Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A (2004) 4.17
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A (2006) 3.55
Diagnosing autism: analyses of data from the Autism Diagnostic Interview. J Autism Dev Disord (1997) 3.45
The pre-linguistic autism diagnostic observation schedule. J Autism Dev Disord (1995) 3.26
Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol Dis (2008) 2.88
Cognitive profiles and social-communicative functioning in children with autism spectrum disorder. J Child Psychol Psychiatry (2002) 2.80
The immune response in autism: a new frontier for autism research. J Leukoc Biol (2006) 2.65
Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord (2010) 2.59
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun (2008) 2.50
Elevated immune response in the brain of autistic patients. J Neuroimmunol (2009) 2.46
Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun (2010) 2.19
Recent advances in the genetics of autism. Biol Psychiatry (2006) 2.11
Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (2007) 2.02
Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology (2007) 1.87
Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol (2005) 1.85
Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med (2005) 1.81
Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol (2003) 1.69
Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol (1999) 1.66
The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest (2009) 1.66
Maternal antibrain antibodies in autism. Brain Behav Immun (2006) 1.62
Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features. Blood (2006) 1.60
Activation of the inflammatory response system in autism. Neuropsychobiology (2002) 1.56
Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol (2006) 1.53
A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol (2005) 1.49
Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology (2005) 1.47
Quantifying the phenotype in autism spectrum disorders. Am J Med Genet (2001) 1.46
Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model. J Neuroimmunol (2009) 1.40
Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics (2009) 1.37
Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol (1998) 1.25
Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc Natl Acad Sci U S A (1994) 1.25
Antibodies against fetal brain in sera of mothers with autistic children. J Neuroimmunol (2008) 1.24
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A (2010) 1.16
Further evidence that the rs1858830 C variant in the promoter region of the MET gene is associated with autistic disorder. Autism Res (2009) 1.16
A review of autism and the immune response. Clin Dev Immunol (2004) 1.15
Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation (2008) 1.14
Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther (2003) 1.14
Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry (2001) 1.14
Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J Exp Med (1997) 1.13
Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res (2005) 1.12
Behavioral correlates of maternal antibody status among children with autism. J Autism Dev Disord (2012) 1.11
Hepatocyte growth factor modulates interleukin-6 production in bone marrow derived macrophages: implications for inflammatory mediated diseases. PLoS One (2010) 1.10
Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood (2000) 1.08
Hepatocyte growth factor is a regulator of monocyte-macrophage function. J Immunol (2001) 1.05
Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling. Am J Respir Cell Mol Biol (2004) 1.05
Association of MET with social and communication phenotypes in individuals with autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 1.05
Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood (1997) 1.04
Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol (2007) 1.04
Abnormal psychosocial situations and ICD-10 diagnoses in children and adolescents attending a psychiatric service. J Child Psychol Psychiatry (1992) 1.03
Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol (2005) 1.03
Low-grade endotoxemia in patients with severe autism. Neurosci Lett (2010) 0.99
Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J Pediatr Surg (2004) 0.99
Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. Cell Growth Differ (1996) 0.97
Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease. Biomark Insights (2009) 0.96
Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation (2004) 0.91
Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther (2006) 0.86
Gas chromatographic measurement of levels of fenfluramine and norfenfluramine in human plasma, red cells and urine following therapeutic doses. J Chromatogr (1970) 2.97
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene (1998) 2.59
Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet (1998) 2.31
Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration. Br J Pharmacol (1971) 2.23
Clinical trials of an intravenous oxygenator in patients with adult respiratory distress syndrome. Anesthesiology (1992) 2.11
Pancreatic abscess associated with Achromobacter group Vd biovar 1. J Clin Microbiol (1980) 1.75
Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry (2002) 1.67
Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci U S A (1988) 1.63
Fenfluramine overdosage. Lancet (1969) 1.59
Intrapulmonary benign fibrous tumor of the pleura. J Thorac Cardiovasc Surg (1995) 1.55
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest (1998) 1.52
Autism-specific maternal autoantibodies recognize critical proteins in developing brain. Transl Psychiatry (2013) 1.46
Pulsar NP 0532: properties and systematic polarization of individual strong pulses at 430 MHz. Nature (1970) 1.39
Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol (2001) 1.28
Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect (1999) 1.26
In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology (1997) 1.20
Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol (1998) 1.17
A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry (2006) 1.12
Endoluminal gastroplication in children with significant gastro-oesophageal reflux disease. Gut (2004) 1.10
Mutations that affect ion channels change the sensitivity of Drosophila melanogaster to volatile anesthetics. J Neurogenet (1995) 1.09
New mutants of Drosophila that are resistant to the anesthetic effects of halothane. Ann N Y Acad Sci (1991) 1.08
Maternal immune activation and strain specific interactions in the development of autism-like behaviors in mice. Transl Psychiatry (2013) 1.07
A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.06
Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot Essent Fatty Acids (2006) 1.04
Aortic valve replacement and combined aortic valve replacement and coronary artery bypass grafting: predicting high risk groups. J Am Coll Cardiol (1987) 1.03
Comparison of the time course of the anorectic effect of fenfluramine and amphetamine with drug levels in blood. J Pharm Pharmacol (1975) 1.03
Characterization of antimitochondrial antibodies in health adults. Hepatology (1998) 1.01
Maternal antibodies from mothers of children with autism alter brain growth and social behavior development in the rhesus monkey. Transl Psychiatry (2013) 1.00
Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Hepatology (2001) 0.98
Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun (2000) 0.97
Genes within the HLA class II region confer both predisposition and resistance to primary biliary cirrhosis. Tissue Antigens (1994) 0.96
Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis. Hepatology (1999) 0.96
Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology (1990) 0.96
Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology (1995) 0.93
Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation. Clin Immunol (1999) 0.93
Effects of a Spirulina-based dietary supplement on cytokine production from allergic rhinitis patients. J Med Food (2005) 0.92
Cryptic antigenic determinants on the extracellular pyruvate dehydrogenase complex/mimeotope found in primary biliary cirrhosis. A probe by affinity mass spectrometry. J Biol Chem (1996) 0.91
Binary asteroids in the near-Earth object population. Science (2002) 0.91
Avian scleroderma: evidence for qualitative and quantitative T cell defects. J Autoimmun (1992) 0.91
The biodisposition of almitrine bismesylate in man: a review. Eur J Respir Dis Suppl (1983) 0.90
H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis (1998) 0.90
Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. I. Cerebral cortex. Neuroscience (2006) 0.89
Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis. Hepatology (1997) 0.89
Fenfluramine overdosage. Lancet (1969) 0.88
An ultra rapid method for the extraction of drugs from biological fluids. J Chromatogr (1971) 0.87
Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun (1998) 0.87
A study of antimitochondrial antibodies in a random population in Estonia. Am J Gastroenterol (1997) 0.86
Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Mod Pathol (1994) 0.86
The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies. Xenobiotica (1989) 0.85
Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis. Hepatology (1994) 0.85
Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis. J Autoimmun (1997) 0.85
Mortality of coronary artery bypass grafting before and after the advent of angioplasty. Ann Thorac Surg (1989) 0.84
Should elective repair of coarctation of the aorta be done in infancy? J Thorac Cardiovasc Surg (1984) 0.84
Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjögren's syndrome. Hepatology (1994) 0.84
The effect of cocoa procyanidins on the transcription and secretion of interleukin 1 beta in peripheral blood mononuclear cells. Life Sci (2000) 0.84
Hydroxyethylation of hemoglobin by 1-(2-chloroethyl)-1-nitrosoureas. Chem Res Toxicol (1991) 0.84
Molecular characterization of the mitochondrial autoantigens in primary biliary cirrhosis. Immunol Res (1991) 0.84
Mechanical support of the circulation followed by cardiac transplantation. J Thorac Cardiovasc Surg (1986) 0.84
Ganglioglomerular nerves influence responsiveness of cat carotid body chemoreceptors to almitrine. J Auton Nerv Syst (1989) 0.83
Fenfluramine and methylcellulose in the treatment of obesity: the relationship between plasma drug concentrations and therapeutic efficacy. Postgrad Med J (1975) 0.83
Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2). Proc Natl Acad Sci U S A (1996) 0.82
The pharmacology and clinical pharmacology of indapamide. Postgrad Med J (1981) 0.82
Generation of monoclonal antibodies to murine bile duct epithelial cells: identification of annexin V as a new marker of small intrahepatic bile ducts. Hepatology (1999) 0.82
Molecular aspects and the pathological basis of primary biliary cirrhosis. J Autoimmun (1996) 0.81
Clinical-pathologic conference in thoracic surgery: basaloid squamous carcinoma of the trachea. J Thorac Cardiovasc Surg (2000) 0.81
L-type calcium channel regulation of abnormal tyrosine hydroxylase expression in cerebella of tottering mice. Ann N Y Acad Sci (1999) 0.81
Plasma fenfluramine levels, weight loss and side effects: a failure to find a relationship. Int J Obes (1982) 0.81
Quantification of retinal pigment epithelial phenotypic variation using laser scanning cytometry. Mol Vis (2010) 0.81
Effect of cocoa flavanols and their related oligomers on the secretion of interleukin-5 in peripheral blood mononuclear cells. J Med Food (2002) 0.80
Effects of subchronic d-fenfluramine on splenic immune functions in young and old male and female Fischer 344 rats. Int J Immunopharmacol (1991) 0.80
The use of absorbable monofilament polydioxanone suture in pediatric cardiovascular operations. J Thorac Cardiovasc Surg (1986) 0.80
Thymic microenvironmental abnormalities in MRL/MP-lpr/lpr, BXSB/MpJ Yaa and C3H HeJ-gld/gld mice. J Autoimmun (1995) 0.80
Bacterial artificial chromosome transgenic analysis of dynamic expression patterns of regulator of G-protein signaling 4 during development. II. Subcortical regions. Neuroscience (2006) 0.80
Neuroendocrine and neurochemical responses to novelty stress in young and old male F344 rats: effects of d-fenfluramine treatment. Pharmacol Biochem Behav (1993) 0.80
Risks of mitral valve replacement and mitral valve replacement with coronary artery bypass. Ann Thorac Surg (1985) 0.79
Bridge to heart transplantation: the Penn State experience. J Heart Transplant (1987) 0.79
Long-term results of ventricular assist pumping in postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg (1987) 0.78
Spontaneous T(H)1 cytokine production by intraepithelial but not circulating T cells in infants with or without food allergies. Allergy (2004) 0.78
Cholangiocytes and primary biliary cirrhosis: prediction and predication. J Clin Invest (2001) 0.78
Induction and persistence of immune-mediated cholangiohepatitis in neonatally thymectomized mice. Clin Immunol Immunopathol (1998) 0.78
Traumatic adult respiratory distress syndrome. Chest Surg Clin N Am (1997) 0.77
Short term effects and urinary excretion of the new diuretic, indapamide, in normal subjects. Eur J Clin Pharmacol (1974) 0.77
Is there a serological difference between men and women with primary biliary cirrhosis? Am J Gastroenterol (1999) 0.77
Home blood glucose monitoring in non-insulin-dependent diabetics: the effect of gliclazide on blood glucose and weight control, a multicentre trial. Diabet Med (1985) 0.77
Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in mouse, rat, dog and man. Xenobiotica (1992) 0.77
Responses to novelty stress in female F344 rats: effects of age and d-fenfluramine treatment. Pharmacol Biochem Behav (1996) 0.77
Comparative uptake of calcium from milk and a calcium-rich mineral water in lactose intolerant adults: implications for treatment of osteoporosis. Am J Prev Med (1992) 0.76
Biliary epithelial expression of pyruvate dehydrogenase complex in primary biliary cirrhosis: an immunohistochemical and immunoelectron microscopic study. Hum Pathol (1995) 0.76
Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes. J Autoimmun (1996) 0.76
Plasma fenfluramine levels, weight loss, and side effects. Br Med J (1977) 0.76
Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies. Liver (1997) 0.76
Gastrocystoplasty: technical and metabolic characteristics of the most versatile childhood bladder augmentation modality. J Pediatr Surg (1995) 0.75
Mononuclear cells isolated from fibrotic skin lesions in avian scleroderma constitutively produce fibroblast-activating cytokines and immunoglobulin M. Int Arch Allergy Immunol (1995) 0.75
Proceedings: The relationship between fenfluramine and norfenfluramine blood levels and anoretic activity in the rat. Br J Pharmacol (1975) 0.75